Christophe Arbogast

Title: Christophe Arbogast: Innovator in Angiogenesis Research

Introduction

Christophe Arbogast is a notable inventor based in Viuz en Sallaz, France. He has made significant contributions to the field of biotechnology, particularly in the area of angiogenesis. With a total of 9 patents to his name, Arbogast's work focuses on the development of innovative therapeutic and diagnostic tools.

Latest Patents

Among his latest patents are the KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. This invention provides polypeptides, peptide dimers, and multimeric complexes that include at least one binding moiety for the KDR or VEGF/KDR complex. These innovations have a variety of applications in treating, detecting, isolating, or localizing angiogenesis, which is crucial in various medical conditions. The synthetic, isolated polypeptides are capable of binding to the KDR or VEGF/KDR complex with high affinity, making them valuable in medical diagnostics and treatment protocols.

Career Highlights

Christophe Arbogast has worked with prominent companies in the biotechnology sector, including Dyax Corporation and Bracco Suisse Sa. His experience in these organizations has contributed to his expertise in developing cutting-edge solutions for medical challenges related to angiogenesis.

Collaborations

Throughout his career, Arbogast has collaborated with notable professionals in the field, including Philippe Bussat and Karen E Linder. These partnerships have enhanced his research and development efforts, leading to significant advancements in his area of expertise.

Conclusion

Christophe Arbogast is a distinguished inventor whose work in angiogenesis has led to important innovations in medical diagnostics and therapies. His contributions continue to impact the field positively, showcasing the importance of research and development in biotechnology.